Expression of serum miR-200a, miR-200b and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features (vol 17, pg 779, 2015)

Zuberi M.; Mir R.; Das J.; Ahmad I.; Javid J.; Yadav P.; Masroor M.; Ahmad S.; Ray P. C.; Saxena A.

首页> 外文期刊>Clinical & translational oncology : >Expression of serum miR-200a, miR-200b and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features (vol 17, pg 779, 2015)

【24h】

Expression of serum miR-200a, miR-200b and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features (vol 17, pg 779, 2015)

机译：血清miR-200a，miR-200b和miR-200c作为候选生物标记物在上皮性卵巢癌中的表达及其与临床病理特征的关系（第17卷，第779页，2015年）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical & translational oncology :》 |2015年第10期|共1页
作者
Zuberi M.; Mir R.; Das J.; Ahmad I.; Javid J.; Yadav P.; Masroor M.; Ahmad S.; Ray P. C.; Saxena A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Expression of serum miR-200a, miR-200b and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features (vol 17, pg 779, 2015) [J] . Zuberi M., Mir R., Das J., Clinical & translational oncology : . 2015,第10期

机译：血清miR-200a，miR-200b和miR-200c作为候选生物标记物在上皮性卵巢癌中的表达及其与临床病理特征的关系（第17卷，第779页，2015年）
2. Erratum to: Expression of serum miR-200a, miR-200b and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features [J] . M. Zuberi, R. Mir, J. Das, Clinical and Translational Oncology . 2015,第10期

机译：勘误至：血清miR-200a，miR-200b和miR-200c作为候选生物标志物在上皮性卵巢癌中的表达及其与临床病理特征的关系
3. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features [J] . M. Zuberi, R. Mir, J. Das, Clinical and Translational Oncology . 2015,第10期

机译：血清miR-200a，miR-200b和miR-200c作为候选生物标志物在上皮性卵巢癌中的表达及其与临床病理特征的关系
4. Quantitative proteomic discovery of candidate serum biomarkers for early detection of ovarian cancer [C] . M.R. Russell, M.J. WAlker, A.J.K Williamson, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：候选血清生物标志物预期检测卵巢癌的定量蛋白质组学发现
5. Diagnostic and prognostic relevance of circulating exosomal miR-373 miR-200a miR-200b and miR-200c in patients with epithelial ovarian cancer [O] . Xiaodan Meng, Volkmar Müller, Karin Milde-Langosch, 2016

机译：循环外泌体miR-373miR-200amiR-200b和miR-200c在卵巢上皮癌患者中的诊断和预后相关性
6. Erratum to: Expression of serum miR-200a, miR-200b and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features [O] . M. Zuberi, R. Mir, J. Das, 2015

机译：错误：血清MiR-200a，miR-200b和mir-200c表达作为上皮性卵巢癌中的候选生物标志物及其与临床病理学特征的关联

Expression of serum miR-200a, miR-200b and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features (vol 17, pg 779, 2015)

著录项

相似文献

相关主题

期刊订阅